P

Precision AQ

Data-driven drug access and launches

Clinical Trial Manager/Senior Clinical Trial Manager

Full-TimeUpdated on 10/3/2026
$110.7k - $200.9k+ Discretionary annual bonus
Senior, Expert
Bachelor's
Remote in USA
Remote
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree or equivalent combination of education and experience in a science or health-related field is required.
  • At least 7 years of clinical research experience, or proven competencies for the position, with significant clinical monitoring experience is required.
  • Experience with Microsoft Office products, including Outlook, Word, Excel, and PowerPoint, is required.
  • Ability to travel domestically and internationally, including overnight stays, is required.
  • Mastery of ICH-GCP, relevant company standard operating procedures, and regulatory guidance, with the ability to implement them, is required.
  • Working knowledge of clinical management techniques and tools is required.
  • Direct work experience in a cross-functional environment is required.
  • Proven experience in functional management, including delegating while fostering cohesive team dynamics, is required.
  • Proven experience in planning, risk management, and change management is required.
  • In-depth proven experience in pharmaceutical and/or device research is required.
  • Proven experience with independent negotiation and conflict-management strategies is required.
  • Candidates must be legally authorized to work in the country of employment without employer sponsorship.
Responsibilities
  • Serve as the clinical trial lead responsible for planning, conducting, and overseeing the operational portion of clinical studies within the defined scope of work, ensuring studies comply with the protocol, standard operating procedures, ICH-GCP, and applicable regulatory requirements.
  • Act as the primary clinical point of contact with the client.
  • Collaborate with the project manager on monthly invoicing and clinical-budget variance management.
  • Develop study-related clinical documents, including clinical plans, informed consent form templates, study-specific forms and manuals, case report form completion guidelines, study trackers, pre-study and site initiation visit slides, and other training materials.
  • Identify and develop study-specific training needs for clinical research associates and third-party vendors, including presenting training at investigator meetings and study kick-off meetings.
  • Generate potential site lists with key stakeholders and drive the site-feasibility process.
  • Identify potential risks to enrollment targets based on feasibility analysis and sites’ contracted commitments.
  • Develop and finalize country recruitment and retention strategies.
  • Develop timely communications and working relationships with investigators and the study team to support feasibility, site start-up, enrollment, maintenance, and close-out procedures.
  • Lead internal clinical team meetings and set expectations for clinical research associates and clinical trial assistants.
  • Address clinical research associate and site questions and maintain a frequently asked questions log as appropriate.
  • Support the planning and conduct of investigator meetings.
  • Review and/or approve investigational product release packages.
  • Oversee, support, and track submissions and approvals to competent authorities and institutional review boards or ethics committees in conjunction with regulatory departments, as applicable.
  • Develop clinical monitoring strategies to ensure study timelines and quality deliverables are met.
  • Generate and use metric reporting, including clinical trial management system reports, data-management query trends, and outstanding monitoring reports, to ensure studies follow plan and communicate issues to project managers and clinical research associates as appropriate.
  • Be responsible for electronic trial master file implementation and management.
  • Collaborate with project managers, clinical research associates, and quality assurance to develop corrective and preventive action plans and ensure their implementation and timely closure.
  • Assist sites, internal staff, and clinical research associates with preparation for Good Clinical Practice audits.
  • Work with the project manager on project-specific resourcing issues.
  • Escalate pertinent clinical research associate performance and site-compliance issues when necessary.
  • Collaborate with data management and clinical research associates to ensure data quality and compliance with data-cleaning timelines.
  • Manage investigational product processes, including drug accountability and reconciliation.
  • Assume project-management responsibility as needed when a cross-functional project manager is not assigned to a program.
  • Support business-development and marketing activities as appropriate.
  • Negotiate site budgets and investigator contracts as needed, with support from the legal department and/or site contracts group.
  • Review site-visit reports and ensure monitoring, including scheduling and scope, is performed according to the monitoring plan as needed.
  • Manage clinical vendors, such as laboratories, investigational product providers, patient diaries, and home health care providers, in conjunction with the project manager as needed.
  • Perform clinical data review of patient profiles, data listings, and summary tables, including query generation, as needed.
  • Perform line-management responsibilities as applicable.
  • Perform other duties as assigned by management.
Desired Qualifications
  • An advanced degree is preferred.

About the company

Precision AQ helps pharmaceutical companies get FDA-approved medicines to patients by using data, evidence, and market insights to shape access and launches. Its services combine medical science, commercial strategy, and technology development to create new pathways for drug availability and timely delivery. The company partners with drug makers to plan launches and expansion, using analytical and creative approaches to make medicines reachable and effective in real-world settings. Unlike firms that focus only on science or marketing, Precision AQ blends data-driven insights with strategic execution across development and commercialization to accelerate patient access. The goal is to raise standards in healthcare accessibility and impact by getting the right medicines to the right patients faster.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Precision AQ

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 17, 2026 hires Yahya Anvar and Emma Hawe deepen AI and HTA capabilities.
  • August 12, 2026 Candice Subero hire boosts marketing-led customer engagement and commercial growth.
  • Precision AQ’s 2025 Phluence investment advances agentic patient solutions, reducing post-Rx service costs.

What critics are saying

  • Precision AQ reported $314.5 million revenue in 2024, down 7%, signaling slower growth.
  • Phluence integration in November 2025 risks distracting teams while AI patient-service economics remain unproven.
  • If pharma shifts to in-house AI access tools, Precision AQ’s HUB model weakens.

What makes Precision AQ unique

  • Precision AQ works with all top 30 pharma companies and 350+ active engagements in 2026.
  • Its 2024 rebrand unified pricing, HEOR, medical affairs, and omnichannel capabilities under one platform.
  • Precision AQ has launched over 450 drugs, creating embedded launch expertise across therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Sick Leave

Parental Leave

Performance Bonus

Company News

PR Newswire
Feb 17th, 2026
Precision AQ expands leadership with AI and data strategy hires to strengthen global biopharma solutions

Precision AQ, a global life sciences commercialisation partner, has appointed two senior leaders to expand its AI and data capabilities. Emma Hawe joins as Senior Vice President, Managing Director for Evidence Synthesis & Decision Modelling, bringing over 25 years of experience in evidence generation and applied statistics. She currently chairs ISPOR's HEOR Excellence—Methodology Award. Yahya Shaikh becomes Senior Vice President, Data Strategy & AI, focusing on strengthening the company's data foundation and advancing AI-enabled solutions. He brings decades of experience in AI, analytics and enterprise data strategy across life sciences and healthcare. The appointments aim to bolster Precision AQ's presence in the EU whilst expanding its global reach. The company works with all 30 top pharmaceutical firms and has launched over 450 drugs across therapeutic areas.

StreetInsider
Nov 18th, 2025
Precision AQ Invests in Phluence Platform

Precision AQ has made a strategic investment in Phluence, enhancing its post-prescription capabilities. This investment allows pharmaceutical manufacturers to virtualize patient services, reduce costs, and improve access through Phluence's advanced agentic workflow management platform. The collaboration aims to modernize patient engagement with AI-driven solutions, offering an alternative to traditional HUB models. This move supports Precision AQ's goal to streamline patient services and accelerate access to therapies.

PR Newswire
Apr 25th, 2025
Precision Aq Expands Industry-Leading Access Experience Team (Aet) With Three Oncology Experts

-- Shraddha Kansagra, PharmD, BCOP, former Clinical Pharmacy Specialist at UT Southwestern, appointed Vice President, Clinical Oncology Solutions ---- Angelica Norrell, PharmD, BCOP, CSP, former Senior Director of Product at Optum, joins as Senior Director, AET ---- Courtney Patterson, PharmD, MBA, former System Director of Oncology Pharmacy Services at Advocate Health, joins as Vice President, Clinical Oncology Solutions --NEW YORK, April 25, 2025 /PRNewswire/ -- Precision AQ, a leader in life sciences commercialization and a driving force in expanding patient access to life-changing therapies, today announced the additions of Shraddha Kansagra, PharmD, BCOP, Angelica Norrell, PharmD, BCOP, CSP, and Courtney Patterson, PharmD, MBA to its Access Experience Team (AET). These experts join Precision AQ's AET, an industry-leading team of former access decision-makers and influencers, to provide critical insights to life science companies and support them in anticipating payer challenges and designing strategies to optimize patient access in oncology.As access decisions in oncology increasingly incorporate both payer and provider perspectives, the additions of Drs. Kansagra, Norrell, and Patterson reflect Precision AQ's commitment to evolving with the landscape. Precision AQ's AET boasts numerous oncology experts, including five Board Certified Oncology Pharmacists (BCOPs), from prominent payer and provider-based institutions across the United States. These new additions further bolster the AET's expertise and capabilities, including driving medical and pharmacy benefit management for Value Based Care, drug coverage policy and formulary design; optimizing patient care through quality improvement initiatives; and overseeing pharmacy and healthcare operations."We are delighted to welcome Shraddha, Angie, and Courtney to Precision AQ, bolstering our AET with additional expertise in oncology, one of the most innovative areas in healthcare," said Chad Clark, President and Chief Operating Officer of Precision Medicine Group. "Together with our existing roster of top-tier access decision makers, as well as our external network of over 100 oncology advisors from leading U.S

PR Newswire
Mar 31st, 2025
Precision Aq Earns Hitrust Implemented, 1-Year I1 Certification For Data Protection And Cybersecurity Risk Management

HITRUST i1 certification confirms Precision AQ's commitment to protecting sensitive data with leading security practices.NEW YORK, March 31, 2025 /PRNewswire/ -- Precision AQ, a leader in guiding life science organizations through the complexities of product commercialization and empowering access to life-changing medicines for all, announced today that its PatientLens platform has achieved HITRUST certification for system and information security.PatientLens transforms healthcare insights and patient program design by reducing friction in patient services and by delivering timely, actionable information to support decision-making. The platform offers a detailed view of insurance coverage, out-of-pocket costs, and medical or medication history. By leveraging tokenized patient data and advanced analytics, PatientLens helps healthcare organizations optimize patient outreach, prioritize cases, and ensure compliance, driving improved outcomes and operational efficiency.The HITRUST Implemented, 1-Year i1 validated assessment and certification process confirms that the PatientLens platform applies a robust set of HITRUST-curated controls. These controls ensure the organization follows leading security practices and maintains a comprehensive cybersecurity program to defend against cyber threats. HITRUST continuously analyzes cyber threat intelligence to keep its control requirements relevant, helping organizations mitigate emerging risks like phishing, brute force attacks, and ransomware, and supporting organizational resilience."The HITRUST i1 validated assessment is a powerful tool for cyber-aware organizations, such as Precision AQ," said Robert Booker, Chief Strategy Officer at HITRUST. "This certification assures the measurement, implementation, and performance of robust information security controls

GlobeNewswire
Mar 4th, 2025
Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a...